Essential Tremor - Pipeline Review, H1 2016

  • ID: 3774197
  • Report
  • 49 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Merz GmbH & Co. KGaA
  • Sage Therapeutics, Inc.
  • MORE
Essential Tremor - Pipeline Review, H1 2016

Summary

‘Essential Tremor - Pipeline Review, H1 2016’, provides an overview of the Essential Tremor pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Essential Tremor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Essential Tremor and features dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Essential Tremor
- The report reviews pipeline therapeutics for Essential Tremor by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Essential Tremor therapeutics and enlists all their major and minor projects
- The report assesses Essential Tremor therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Essential Tremor

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Essential Tremor
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Essential Tremor pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Merz GmbH & Co. KGaA
  • Sage Therapeutics, Inc.
  • MORE
List of Tables

List of Figures

Introduction

Report Coverage

Essential Tremor Overview

Therapeutics Development

Pipeline Products for Essential Tremor - Overview

Essential Tremor - Therapeutics under Development by Companies

Essential Tremor - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Essential Tremor - Products under Development by Companies

Essential Tremor - Companies Involved in Therapeutics Development

Merz GmbH & Co. KGaA

Neurocrine Biosciences, Inc.

Sage Therapeutics, Inc.

Essential Tremor - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

incobotulinumtoxin A - Drug Profile

Product Description

Mechanism of Action

R&D Progress

NBI-640756 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

SAGE-217 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

sepranolone - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Antagonize GPCR for Central Nervous System Diseases - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Essential Tremor - Recent Pipeline Updates

Essential Tremor - Dormant Projects

Essential Tremor - Discontinued Products

Essential Tremor - Product Development Milestones

Featured News & Press Releases

Apr 17, 2016: Sage Therapeutics Expands Scientific, Clinical and Burden of Illness Data for SAGE-547 in SRSE and Essential Tremor at the 2016 American Academy of Neurology Annual Meeting

Nov 04, 2015: Neurocrine Biosciences Announces Expansion of its Clinical Pipeline

Sep 03, 2015: SAGE Therapeutics Announces Results From Successful Exploratory Trial in Essential Tremor

Oct 23, 2014: SAGE Therapeutics Initiates Exploratory Study of SAGE-547 in Essential Tremor

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Essential Tremor, H1 2016

Number of Products under Development by Companies, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Comparative Analysis by Early Stage Development, H1 2016

Products under Development by Companies, H1 2016

Essential Tremor - Pipeline by Merz GmbH & Co. KGaA, H1 2016

Essential Tremor - Pipeline by Neurocrine Biosciences, Inc., H1 2016

Essential Tremor - Pipeline by Sage Therapeutics, Inc., H1 2016

Assessment by Monotherapy Products, H1 2016

Number of Products by Stage and Target, H1 2016

Number of Products by Stage and Mechanism of Action, H1 2016

Number of Products by Stage and Route of Administration, H1 2016

Number of Products by Stage and Molecule Type, H1 2016

Essential Tremor Therapeutics - Recent Pipeline Updates, H1 2016

Essential Tremor - Dormant Projects, H1 2016

Essential Tremor - Discontinued Products, H1 2016

List of Figures

Number of Products under Development for Essential Tremor, H1 2016

Number of Products under Development by Companies, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Assessment by Monotherapy Products, H1 2016

Number of Products by Targets, H1 2016

Number of Products by Stage and Targets, H1 2016

Number of Products by Mechanism of Actions, H1 2016

Number of Products by Stage and Mechanism of Actions, H1 2016

Number of Products by Routes of Administration, H1 2016

Number of Products by Stage and Routes of Administration, H1 2016

Number of Products by Molecule Types, H1 2016

Number of Products by Stage and Molecule Types, H1 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Merz GmbH & Co. KGaA
Neurocrine Biosciences, Inc.
Sage Therapeutics, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll